Cartalax is a synthetic tripeptide bioregulator with the sequence Ala-Glu-Asp. It is provided as a lyophilized powder in a 3ml vial for research use only.Sequence: Ala-Glu-Asp (AED)Molecular Formula: C₁₂H₁₉N₃O₈Molecular Weight: 333.29 Da (free acid)Synonyms: AED peptide, T-31, Alanyl-glutamyl-aspartic acidPurity: ≥98% (HPLC)Form: Lyophilized white powderQuantity: 20 mg per vialSolubility: Soluble in sterile water or bacteriostatic waterIntended Use:This product is intended strictly for in vitro and in vivo laboratory research purposes. Cartalax is commonly studied in regenerative medicine, gerontology, and connective tissue research for its potential effects on chondrocytes, fibroblasts, and extracellular matrix regulation in cartilage and joint models.Key Research Areas:• Cartilage and connective tissue regeneration• Modulation of gene expression in chondrocytes and fibroblasts• Support of extracellular matrix homeostasis• Age-related changes in joint and connective tissue
Amino Acids/Research Peptides
Cartalax (AED) 15mg
$50.00
Cartalax is a synthetic tripeptide bioregulator with the sequence Ala-Glu-Asp. It is provided as a lyophilized powder in a 3ml vial for research use only.
RUO Compliant Product Description for Cartalax 15mg
For Research Use Only. Not for human consumption, diagnostic, or therapeutic use. This product is not approved by the FDA or any other regulatory agency for use in humans or animals. Handle according to standard laboratory safety protocols for peptides. Researchers must ensure compliance with all local, state, and federal regulations regarding the use of research chemicals.
No FAQs added for this product yet.





Reviews
There are no reviews yet.